Download - Valve Replacement in Infective Endocarditis
Valve Replacement in Infective Endocarditis
PJA SlabbertCardiology
Patient history
34 year male from NCAdmitted KHC : 23/3/10 to 8/4/10 for Infective Endocarditis (culture negative) Pen G and Gentamycin
Clinically deteriorated over 3 days and follow up echocardiogram showed: Worsening heart failure More extensive vegetations on aorta
valves
Systemic enquiry: Neurology: no TIA, no amurosis fugax Respiratory: 3 weeks non productive cough,
progressive dyspnoea Cardiology: Angina on exertion, ortopnea,
PND, dyspnoea NYHA grade 4, ankle swelling, no sharp chest pain radiating to back.
Gastro-enterology: vomited previous night.
Previous medical Hx: D-E-A-T-H-, not known with cardiac condition,
no chronic medication
ExaminationGeneral: Chronically ill: underweight J-A-C-C-O+L- BP 121/52 (no cardiogenic shock, wide pulse
pressure), HR 92/m, normal temperature, RR 33/m, saturation 98% on 40% oxygen
Diffuse fungal/ yeast skin infection: Pityriasis versicolor
No peripheral manifestations of infective endocarditis: Roth spots, subungual hemorrhages, Janeway lesions
Cardiovascular Water hammer pulse, equal pulses and
BP left and right. Elevated JVP 2cm above baseline
Apex displaced inferior lateral: 6th ics aal
Loud P2, C3 both ventricles Decrescendo diastolic murmur
parasternally with ejection systolic murmur not radiating. No Austin Flint
Respiratory: Diffuse inspiratory crackles Distressed : tachypnoea, accessory
muscle use.
Abdomen: No Hepatomegaly, No splenomegaly
Urine Dipstix : no microscopic hematuria
Problem List
Infective EndocarditisSevere Aorta Regurgitation with signs of bi-ventricular failurePulmonary edema with acute respiratory failure
Special investigationBloods: FBC : WCC 8.4, Hb 14.1, plt 191 U&E : Na 136, K 5.2, Urea 17.6, Cr 133 LFT : t-prot 72, alb 25, t-Billi 35, c-Billi 16, ALP
109, GGT 108, AST 165, ALT 293, LDH 150 CRP 5.2 Trop-T : negative, CK : normal ASOT negative, ANA negative, RF negative,
RPR negative, HIV negative BC negative
Cardiac echo CXR ECG
ECG
CXR
echoAorta root diameter = 30 mm (normal)Aorta valve opening = 21 mm (normal)Vegetation on all three aorta cuspsPressure half time = 67 ms (<200ms severe acute AR)Mitral valve : mild regurgitationLeft Atrium : 4.3 cm (enlarged)Left ventricle: LVEDD 6.5 cm, LVESD 5 cm, LVEF = 44%Right heart mildly enlarged, mild TI, RVPSP = 65 mmHg
Treatment
Furosemide 40 mg bd iviEnalapril 5 mg bd poElantin 20 mg bd poPen G, Gentamycin, Cloxacillin, DiflucanUrgent cardio-thoracic consult Ross procedure was done
Surgery in NVE
Introduction 1961 : Kay and colleagues excised fungal
vegetation from tricuspid valve 1965 : AVR in IE due to Serratia Marcescens Last 3 decades : valve replacement/ repair
common in Mx of complicated IE Decreased mortality in IE due to
combination of antibiotics and timely surgical intervention
Indications
2006 American College of Cardiology/ American Heart Association (ACC/ AHA) Surgery is warranted for native valve IE who
have one or more of the following 1. Heart failure (moderate to severe) that is directly
related to valve dysfunction. 2. Severe aorta/ mitral regurgitation with evidence
of abnormal hemodinamics, such as elevated LVED or left atrial pressures.
3. Endocarditis due to fungal of high resistant organisms.
4. Peri-valvular infection with abscess/ fistula formation
Other condition considered as possible indications 1. Embolic events while on
appropriate antibiotic regimen or large vegetations (> 10mm in diameter)
2. Large vegetations > 10mm in diameter (even without embolic events) if mobile
Choice of procedure
For active infection (2006 ACC/AHA): Valve repair rather than replacement
Only possible in minority of cases Thus leaflet perforation without
destruction or annular involvement.
Heart Failure
Moderate to severe HF due to IE Medical therapy : mortality rate 75% Medical & surgical : mortality rate 25%
HF is indication in 2/3 to ¾ of casesIE induced AR is more likely to produce HF than IE induced MR (death may occur suddenly in aorta involvement)
Caveats Non cardiac factors that exaggerate HF
Fever, anemia, sepsis, renal insufficiency Hx of previous HF.
HF out of proportion to valve dysfunction.
Complicated infection
Persistent positive BC 5 to 7 days or lack of clinical improvement
after 1 week of appropriate Rx search for metastatic abscess; then
Echocardiographic evidence of perivalvular abcess / fistula formation/ leaflet perforation Serial TEE and early in presence of known
difficult organism.
New heart block
Fungal infection is in general an early indication for Relapse after adequate therapy may require intervention. A 2nd course of antibiotics is only indicated if no perivalvular infection and offending organism is sensitive to Rx.
Embolization
Overall risk : 13 – 44%Decline after effective antimicrobial Rx, thus not necessary to prevent stroke. indicated after a second embolic event after appropriate Rx in patient with persistent vegetations.‘Silent’ emboli, thus screen (CT scan) all patient with large (>1cm) or mobile vegetations prior to
Emboli ( risk)
Cardiopulmonary bypass and need for anticoagulation increases the risk of extending infarct and or converting a nonhemorrhagic infarct into a hemorrhagic lesion.Suggested is postponed 2 weeks after cerebral infarction and 4 weeks after cerebral hemorrhage. May be done before 2 weeks if compelling indications (eg moderate HF).
Emboli (vegetation size)
Larger size larger risk for emboliIn general is not indicated for increase in vegetation size in patient responding well to medical RxVegetations > 10mm by itself is not sufficient to require , unless other complicating features.
Timing of surgery
Concern: placing prosthetic valve in actively infected tissue !Recommendation: should not be delayed with clear indications regardless of duration of pre-operative antibiotics.
Antibiotic following surgery
2004 European Society of Cardiology (ESC): Full course of antibiotic Rx if valve
culture is positive If culture negative, complete full
course counting the pre-operative duration of Rx. Minimum duration 7 to 15 days post operative. Rate of relapse 3/358
Reference
Fauci, AS, Braunwald, E, Harrison’s Principles of Internal Medicine, 17th Edition, 2008Schick, EC, Surgery for native valve endocarditis, Uptodate, June 2008Talley, NJ, O’Conner, S, Clinical examination, 2001
Q & A
Thank you